Endomag is a pioneering company dedicated to revolutionizing breast cancer surgery through innovative magnetic technologies. The company's products, including Magseed, MagseedPro, Magtrace, and the Sentimag platform, aim to prevent unnecessary surgeries, improve surgical outcomes, and increase patient access globally. Trusted by over 1,350 hospitals in more than 45 countries, Endomag's technology has benefited over 500,000 patients. Their approach focuses on providing less invasive, more precise surgery options using advanced magnetic guidance systems. Endomag is committed to enhancing the standard of care for breast cancer treatment worldwide, now as part of Hologic.